by Stephan Schaller | Dec 18, 2024 | Aktuell, Corporate
2024 - Thank You! A Year of Growth, Innovation, and Impact at ESQlabs. Seasonal poem: “May your walls know joy, may every room hold laughter, and every window open to great possibility.” –Mary Anne Radmacher As we close another significant year, we celebrate...
by Stephan Schaller | Dec 10, 2024 | Aktuell
A New joint Initiative to Advance Women’s Health and Tuberculosis Therapies in Regions with Constrained Healthcare Resources ESQlabs GmbH, is pleased to announce a pioneering open-source model-informed drug development (MIDD) project focused on enhancing treatments...
by Stefano Pizzamiglio | May 8, 2024 | Aktuell, Corporate
ESQlabs Announces the Launch of MPSlabs as a Dedicated Business Unit for leveraging modelling and simulation approaches for microphysiological systems. Saterland, Germany, 8th of May, 2024 — ESQlabs GmbH, a leader in biosimulation services and solutions, announces...
by Mark Davies | Mar 17, 2024 | Aktuell, Corporate
ESQlabs recognised in Deloitte Technology Fast 50 Award - 2023 Deloitte honors the fastest growing tech companies in Germany 14th of March 2024 – the Deloitte Technology Fast 50 Award ceremony took place for 21st time, in the heart of Berlin. 50 start-ups...
by Mark Davies | Jan 23, 2024 | Aktuell, Corporate
Happy New Year! Holidays may seem a long time ago, but it's still a Happy New Year! Growth! We finished 2023 with the addition of 13 highly talented new members to the esqLABS family. 2024 has started equally well. and we have welcomed five more new members to the...
by Mark Davies | Dec 18, 2023 | Aktuell, Corporate
Thank You! Thanks to all the collaborators, clients, family, and friends who made 2023 such a success. ChatGPTs seasonal poem: In pharma and chemical realms we are led,With AOP’s insights, we forge ahead,PBK meets QSP in this season of joy,Happy Holidays to all,...
